Mark Wildgust's Avatar

Mark Wildgust

@mawildgust.bsky.social

VP of Oncology Global Medical Affairs at Johnson & Johnson focused on bringing new treatment options for patients with cancer. Posts shared are my own. πŸ‡¬πŸ‡§πŸ‡ΊπŸ‡ΈπŸ³οΈβ€πŸŒˆ

309 Followers  |  151 Following  |  23 Posts  |  Joined: 18.11.2024  |  1.7906

Latest posts by mawildgust.bsky.social on Bluesky

Historically underrepresented in clinical studies, LGBTQIA+ people face systemic barriers that perpetuate health inequities and hinder the advancement of medical knowledge tailored to their needs.

Historically underrepresented in clinical studies, LGBTQIA+ people face systemic barriers that perpetuate health inequities and hinder the advancement of medical knowledge tailored to their needs.

A Comment article in Nature Medicine argues that clinical research should recruit participants from LGBTQIA+ populations, which requires specific actions and policies to create affirming and welcoming environments. https://go.nature.com/3WILuQi πŸ§ͺ

03.02.2025 13:04 β€” πŸ‘ 78    πŸ” 24    πŸ’¬ 0    πŸ“Œ 3
A roadmap for engagement and inclusion of LGBTQIA+ people in clinical research - Nature Medicine Clinical research should recruit participants from LGBTQIA+ populations, and this requires specific actions and policies to create affirming and welcoming environments.

Our mission @J&J is to understand how our medicines work in all pts. I’m honored to have contributed to this ground breaking paper in @naturemedicine.bsky.social identifying a roadmap for inclusion of #LGBTQIA+ individuals. @fenwayhealth.bsky.social #MyCompany

www.nature.com/articles/s41...

09.02.2025 15:54 β€” πŸ‘ 6    πŸ” 1    πŸ’¬ 2    πŸ“Œ 0
Preview
Brief Report: Preventing Infusion-related Reactions With Intravenous Amivantamab: Results From SKIPPirr, a Phase 2 Study Amivantamab, an EGFR–MET bispecific antibody, is approved for multiple indications in EGFR-mutated advanced non-small cell lung cancer (NSCLC) as mono…

Excited to share our #SKIPPirr study was just published. Great job everyone involved in this study. #EGFR #NSCLC #PatientFocus #MyCompany
www.sciencedirect.com/science/arti...

26.01.2025 14:23 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0
Post image Post image

Great to speak at the @statnews.bsky.social panel Stat@ash on our goals in #hematology driving towards transforming outcomes in cancer. #MyCompany

08.12.2024 04:19 β€” πŸ‘ 8    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0
Post image

Great to see the discussion by @statnews.bsky.social on #Sicklecell here #ASH24 at their STAT@ASH event. Great moderating by @adamfeuerstein.bsky.social

08.12.2024 03:07 β€” πŸ‘ 6    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Excited to be speaking on the @statnews.bsky.social panel this evening at #ASH24. Speaking on the innovations in hematology that Johnson & Johnson Innovative Medicine are leading and pioneering. #MyCompany

08.12.2024 02:54 β€” πŸ‘ 5    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Great to see the Bleximenib data being presented here at #ASH24! More progress is needed in AML! #MyCompany

07.12.2024 23:05 β€” πŸ‘ 5    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Preview
a cookie monster is sitting on a kitchen counter next to a measuring cup that says rachael ALT: a cookie monster is sitting on a kitchen counter next to a measuring cup that says rachael

Love being at #ASH24. Finding time to grab something to east isn’t easy! But when you find a snack in a meeting room …. #Hungry

06.12.2024 19:37 β€” πŸ‘ 6    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Heading to #ASH24. Didn’t think there was such a thing as a red eye from the East coast to the West but will land at 2:30am EST in San Diego. πŸ₯±πŸ˜΄.

05.12.2024 02:16 β€” πŸ‘ 8    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0
Post image Post image

As I leave Hong Kong to head home I’m reflecting on a great visit. Strengthening friendships, building new friendships, leading with science and as my friend @tonymokum.bsky.social says over good food!

26.11.2024 01:39 β€” πŸ‘ 4    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image 24.11.2024 14:39 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image 24.11.2024 14:10 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Amazing dinner with Tony and some faculty at the #IOHK24 meeting. Amazing restaurant on Lamma Island.

24.11.2024 14:10 β€” πŸ‘ 5    πŸ” 0    πŸ’¬ 2    πŸ“Œ 0
Post image

Come and join the J&J sponsored satellite symposium here at #IOHK24. Great speaker line up. #MyCompany

24.11.2024 05:33 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Terrific key note presentation by Tony Mok here at #IOHK24 on immunotherapy in #LungCancer.

24.11.2024 02:05 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Great to catch up with @antoniopassaro.bsky.social while at the #IOHK24 meeting.

23.11.2024 14:43 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

So helpful Nathan. Thank you!

23.11.2024 08:41 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Spectacular talk by Prof Maximilian Diehn on ctDNA and MRD in #LungCancer here at #IOHK24!

23.11.2024 04:16 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Looking forward to @solangepeters.bsky.social presentation here at #IOHK24!

23.11.2024 02:48 β€” πŸ‘ 4    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image Post image

Great to be here in #HongKong at #IOHK24 for a terrific meeting. Opening remarks from Tony Mok!

23.11.2024 01:31 β€” πŸ‘ 4    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

He even has JNJ red in his office!

22.11.2024 10:52 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image Post image

In Hong Kong for the Immuno-Oncology meeting. Also got to meet a famous local HK resident/TV star!

22.11.2024 10:50 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

Heading to #ASH24? Love to connect and reconnect with anyone going. Johnson & Johnson Innovative Medicine team will be there in full force, presenting new data across our hematology portfolio. #Mycompany

22.11.2024 10:36 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Happy to join the Bluesky community.

22.11.2024 10:27 β€” πŸ‘ 4    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

@mawildgust is following 19 prominent accounts